Free Trial

Vanguard Capital Wealth Advisors Makes New Investment in Cameco Co. (NYSE:CCJ)

Cameco logo with Basic Materials background

Vanguard Capital Wealth Advisors acquired a new stake in shares of Cameco Co. (NYSE:CCJ - Free Report) TSE: CCO in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 16,330 shares of the basic materials company's stock, valued at approximately $839,000. Cameco makes up 0.9% of Vanguard Capital Wealth Advisors' holdings, making the stock its 20th biggest position.

Several other institutional investors and hedge funds have also recently modified their holdings of CCJ. Norges Bank bought a new position in shares of Cameco in the 4th quarter worth $188,595,000. FMR LLC raised its holdings in Cameco by 8.7% in the fourth quarter. FMR LLC now owns 22,639,647 shares of the basic materials company's stock worth $1,163,942,000 after purchasing an additional 1,811,876 shares in the last quarter. Driehaus Capital Management LLC lifted its position in shares of Cameco by 120.2% during the fourth quarter. Driehaus Capital Management LLC now owns 2,245,539 shares of the basic materials company's stock valued at $115,398,000 after buying an additional 1,225,966 shares during the last quarter. Alliancebernstein L.P. boosted its holdings in shares of Cameco by 13.5% in the 4th quarter. Alliancebernstein L.P. now owns 10,088,407 shares of the basic materials company's stock valued at $518,443,000 after buying an additional 1,196,336 shares in the last quarter. Finally, AGF Management Ltd. raised its stake in shares of Cameco by 54.2% during the 4th quarter. AGF Management Ltd. now owns 3,393,233 shares of the basic materials company's stock worth $174,433,000 after acquiring an additional 1,193,266 shares in the last quarter. Institutional investors own 70.21% of the company's stock.

Cameco Trading Down 0.2%

Shares of Cameco stock opened at $51.16 on Tuesday. The stock's 50 day simple moving average is $43.90 and its 200-day simple moving average is $48.81. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.88 and a quick ratio of 1.26. The stock has a market cap of $22.27 billion, a P/E ratio of 182.71 and a beta of 0.89. Cameco Co. has a 1-year low of $35.00 and a 1-year high of $62.55.

Cameco (NYSE:CCJ - Get Free Report) TSE: CCO last posted its earnings results on Thursday, May 1st. The basic materials company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.07). Cameco had a net margin of 5.39% and a return on equity of 4.34%. The firm had revenue of $549.58 million during the quarter, compared to analyst estimates of $890.07 million. During the same quarter in the previous year, the firm earned $0.13 earnings per share. The business's revenue for the quarter was up 24.4% compared to the same quarter last year. Analysts predict that Cameco Co. will post 1.27 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CCJ has been the subject of several analyst reports. Glj Research increased their price objective on Cameco from $62.76 to $75.68 and gave the company a "buy" rating in a report on Wednesday, March 12th. Scotiabank reissued an "outperform" rating on shares of Cameco in a research report on Wednesday, May 14th. Stifel Nicolaus initiated coverage on shares of Cameco in a report on Wednesday, March 12th. They issued a "buy" rating on the stock. StockNews.com raised shares of Cameco from a "sell" rating to a "hold" rating in a report on Tuesday, May 13th. Finally, Stifel Canada upgraded shares of Cameco to a "strong-buy" rating in a research report on Wednesday, March 12th. One equities research analyst has rated the stock with a hold rating, nine have assigned a buy rating and three have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $70.03.

Get Our Latest Report on CCJ

Cameco Profile

(Free Report)

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.

Further Reading

Institutional Ownership by Quarter for Cameco (NYSE:CCJ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cameco Right Now?

Before you consider Cameco, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cameco wasn't on the list.

While Cameco currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines